27.
Zsanett Zsófia Iván1,2,3, Dominik Hirling1, István Grexa1,2, Bence Magyar1, Alexey Surnov4, Ádám Pap5, Aladár Pettkó-Szandtner5, Nóra Hapek1,3, Enikő Csapó1, Csaba Molnár1,2, András Kriston1,2, Tamás Micsik6,7, Katalin Dobra6,7, László Báthory-Fülöp8, Farkas Sükösd9, Frederik Post10,11, Andreas Mund12,13, Zsuzsanna Darula5, Matthias Mann12,13, Erika Tóth8, Vivien Miczán1, Péter Horváth1,2,4,12
1Institute of Biochemistry, HUN-REN BRC Szeged, Szeged
2Single-Cell Technologies Ltd., Szeged
3Doctoral School of Biology, University of Szeged, Szeged
4Institute of AI for Health, Helmholtz Zentrum München, Neuherberg
5Proteomics Research Group, Core Facility, HUN-REN BRC, Szeged
6Karolinska Institutet, Department of Oncology-Pathology, Solna
7Department of Clinical Pathology and Cytology, Karolinska University Hospital, Solna
8Department of Surgical and Molecular Pathology, Tumor Pathology Center, National Institute of Oncology, Budapest
9Department of Pathology, Péterfy Sándor Street Hospital and Outpatient Clinic, Budapest
10Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried
11Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen
12Institute for Molecular Medicine Finland, University of Helsinki, Helsinki
The Proteomic Landscape of Lung Adenocarcinoma